期刊
ARABIAN JOURNAL OF CHEMISTRY
卷 13, 期 1, 页码 377-392出版社
ELSEVIER
DOI: 10.1016/j.arabjc.2017.05.004
关键词
Diazenyl; Schiff base; Antimicrobial; Anticancer; Fluorescence; Bathochromic
资金
- University Grant Commission [F.25-1/2013-14(BSR)/7-344/2011(BSR)]
A series of diazenyl schiff bases have been synthesized by reaction of salicylaldehyde containing azo dyes with various substituted aniline derivatives in the presence of acetic acid as catalyst. The structures of diazenyl derivatives were determined by FTIR, UV-vis, H-1 NMR, C-13 NMR, CHN analysis, fluorimetric and mass spectroscopic studies. The synthesized derivatives were screened for their in vitro antimicrobial activity against various Gram-positive (S. aureus, B. subtilis, B. cereus), Gram-negative (S. typhi, S. enterica, E. coli, P. aeruginosa) bacterial and fungal (C. albicans, A. niger and A. fumigatus) strains, using cefadroxil (antibacterial) and fluconazole (antifungal) as standard drugs. The diazenyl schiff bases were also screened for their cytotoxicity against human colorectal carcinoma cell line (HCT-116) using 5-fluorouracil as standard drug by Sulforhodamine-B Stain (SRB) assay. The schiff bases exhibited significant activity toward both Gram-positive, Gram-negative bacterial and fungal strains. Most of the synthesized derivatives showed high activity against S. enterica. 4-((2,5-Dichlorophenyl)diazenyl)-2-((3-bromophenylimino)methyl)phenol (SBN-40) was found to be very active against S. aureus, B. cereus and E. coli, with MIC = 0.69 (mu M/ml x 10(2)). The compound 4-((2-bromophenyl)diazenyl)-2-((4-nitrophenylimino)methyl)phe nol (SBN-13) possessed comparable activity (IC50 = 7.5 mu g/ml) to the standard drug 5-fluorouracil (IC50 = 3.0 mu g/ml) against human colorectal carcinoma cell line (HCT-116). (C) 2017 Production and hosting by Elsevier B.V. on behalf of King Saud University.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据